# Study to Investigate the Efficacy of Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cancer

> **NCT02643056** · PHASE2 · COMPLETED · sponsor: **Southern Europe New Drug Organization** · enrollment: 32 (actual)

## Conditions studied

- Advanced Head and Neck Squamous Cancer

## Interventions

- **DRUG:** Panitumumab

## Key facts

- **NCT ID:** NCT02643056
- **Lead sponsor:** Southern Europe New Drug Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02643056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02643056, "Study to Investigate the Efficacy of Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02643056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*